SCHEMBL4011616

SCHEMBL4011616

CCCc1nc(=O)c(Oc2cc(C)ccn2)c(CC)n1Cc1ccc(-c2ccccc2C#N)cc1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.51
AGTR1 P30556 2/20 0.39
ACHE P22303 1/20 0.38
AGTR2 P50052 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4306420 0.90 PPARG (0.52) PPARGAGTR1ACHEAGTR2
SCHEMBL1891409 0.88 PPARG (0.52) PPARGAGTR1AGTR2
SCHEMBL4012577 0.84 PPARG (0.57) PPARGAGTR1ACHEAGTR2
SCHEMBL4012893 0.84 PPARG (0.51) PPARGAGTR1ACHEAGTR2
SCHEMBL4016260 0.83 PPARG (0.52) PPARGAGTR1ACHE
SCHEMBL4016898 0.83 PPARG (0.54) PPARGAGTR1ACHE
SCHEMBL4007590 0.83 PPARG (0.53) PPARGAGTR1ACHE
SCHEMBL4009893 0.81 PPARG (0.51) PPARGAGTR1AGTR2
SCHEMBL4013600 0.79 PPARG (0.49) PPARGAGTR1ACHEAGTR2
SCHEMBL4010668 0.79 PPARG (0.63) PPARGAGTR1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133970-A1 CRYSTALLINE COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-05 WO disclosed
EP-2074117-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2009-07-01 EP disclosed
WO-2008062905-A2 HETEROMONOCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-29 WO disclosed